Eva Jolly, Karolinska Comprehensive Cancer Center, Stockholm, Sweden
Strengthening Cancer Policy through Comprehensive Cancer Centers and Mission Hubs
Silvia Pastoreková, Biomedical Research Center SAS, Bratislava, Slovakia; Scientific Council of the Slovak Academy of Sciences
From Models to Medicine: Experimental Oncology as the Foundation of Clinical Care. The role of the Slovak Academy of Sciences.
Peter Valkovič, Scientific Board of the Ministry of Health, Slovak Republic; Medical Faculty, Comenius University Bratislava, Slovakia
Better Cancer Care for Slovakia: Global Inspiration, Local Progress – Reflections and Hopes
Soňa Čierniková, National Cancer Institute; coordinator of ECHoS, CCI4EU, EUnetCCC-JA activities in Slovakia, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia
Towards a Patient-Centered and Mission-driven Cancer Ecosystem: Slovakia’s Path to Comprehensive Cancer Care and National Cancer Mission Hub
Daniela Světlovská, Department of Clinical Trials, National Cancer Institute, Bratislava, Slovakia
30 years of Clinical Trials Department in National Cancer Institute, Slovakia
Jennifer A. Ligibel, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Cancer Rehabilitation: Preserving Function and Preventing Disability During and After Cancer Treatment
Petra Sládková, Rehabilitation Clinics of the Bulovka University Hospital and the Faculty of Biomedical Engineering of the Czech Technical University, Prague, Czech Republic
Multimodal Prehabilitation in Oncology: Current Options and Perspectives
Barbara Ukropcová, Institute of Experimental Endocrinology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia
Health benefits of aerobic-strength training in TGCT cancer survivors
Richard Crevenna, Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, Austria
Cancer Prehabilitation and Rehabilitation – The Austrian Approach
Shiv K. Singh, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Germany
Emerging Mechanisms of Spatial Heterogeneity Driving Therapy Resistance in Pancreatic Cancer
Bruno Sainz, Cancer Stem Cells and Fibroinflammatory Microenvironment Group Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) – CSIC-UAM, Madrid, Spain
Turning Foes into Allies: Nanoparticle Re-education of Macrophages Against Pancreatic Cancer Metastasis
Michal Kováč, brAInworks Laboratories, Faculty of Informatics and Information Technologies, Slovak University of Technology in Bratislava, Slovakia
How Far Can AI Go in Guiding Cancer Treatment
Eva Steliarova-Foucher, International Agency for Research on Cancer, World Health Organization, Lyon, France
Use of surveillance data in international studies of childhood cancer
Iveta Herichová, Department of Animal Physiology and Ethology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia
Interferences in miRNA and the circadian system in colorectal cancer progression
Ingrid Garajová, Medical Oncology Unit, University Hospital of Parma, Italy
Tumor Microenvironment and Tumor-Neural Cell Interaction in Pancreatic Cancer
Jana Jakubíková, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia
Myeloma Uncovered: From Cells to Clinic via Mass Cytometry
Lucia Kučerová, Translational Research Unit, 2nd Oncology Clinic of the Medical Faculty, Comenius University, and the National Cancer Institute, Bratislava, Slovakia
Recent Advances in Translational Cancer Research in Germ Cell Tumors in Slovakia
